Stifel analyst Alex Thompson reiterated a Buy rating and $49.00 price target on Oruka Therapeutics (NASDAQ: ORKA)The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Form POS AM Oruka Therapeutics, Inc. March 6, 2025 5:18 PM Oruka Therapeutics (ORKA) Misses Q4 EPS by 49cMarch 6, 2025 5:18 PM Form S-8 Oruka Therapeutics, Inc. March 6, 2025 4:49 PM Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateMarch 6, 2025 4:09 PM Form 10-K Oruka Therapeutics, Inc. For: Dec 31March 6, 2025 4:02 PM